(Date:12/1/2009)...very preterm births more likely, British study fin...-- Pregnant women who are poor are more likely to ...en, even though both groups typically receive equa...sity of Leicester research team said their finding...n between economic status and preterm birth. , ...
(Date:12/1/2009)...RLEANS, Dec. 1 The Amer...ual High School Student Symposium at the New Orlea...CST. The symposium, which encourages an interest i... research, is held in conjunction with the Society...ave the opportunity to explore research on sickle ...
(Date:12/1/2009)...NGTON, Dec. 1 On Decemb... 1,538 federal prisoners were HIV positive or had ...BJS) in the Office of Justice Programs, U.S. Depar..., an estimated 5,672 inmates in state and federal ...7. In 2007, about 43 per 10,000 prison inmates wer...
(Date:12/1/2009)...ho would benefit from liver surgery after chemo, s...Day News) -- A CT scan of liver tumors caused by t...erall survival after chemotherapy, researchers rep...c chemotherapy has been shown to improve survival ...to produce better results in patients having surge...
(Date:12/1/2009)... Practitioners of any medical, legal or busines...ing a sigh of relief this week with the release of...on, released over the holiday weekend, allows anyo...ings to do so quickly and seamlessly using just th...WEB) December 1, 2009 -- The iPhone App, released ...
Breaking Medicine News(10 mins):Health News:More Preemies Born Among the Poor 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2...o have optic nerve damage might be at an increased...chers involved 25 people with visual impairment. T... followed for 14 days, and their results were comp...e sleepiness than those with normal sight and peop...
...al called parthenolide is successful in destroying...widely available plant of North America, called fe... treat migraine and rheumatoid arthritis, but this...h and continuation of the disease leukemia.
...
...vitamin B12 are safe and effective in reducing the...aving a stroke . According to researchers stroke p...hip fracture than their healthy peers due to highe... determine if folic acid and vitamin B12 decreases...
...ve disorder where there is a loss of normal bone d...nate if taken daily for 10 years can increase bone...lendronate, have been used for years to treat oste...e next two years. Then for the next five years, wo...
...to children suffering from attention deficit hyper...bility of cancer. //
Although the drug Rital...ncer in animals, this is the first time any study ...alth, The University of Texas, in a study that’s g...
...rs don’t have to use a lot of force or pressure to...body has its own energy or "biomagnetic field" pro...eld can be altered by acupuncture needles, light a... this type of energy medicine works. Orthopedic su...
Other Medicine News:(Date:12/1/2009)...re/ -- MedNet Solutions, a global life sciences te...l study management systems, today announced that ...al technology solution, has been certified by the ...ISC) as complying with the Operational Data Model ...dNet,s commitment to streamlining the entire clini...
(Date:12/1/2009)... 1 The educational resou...mproving Life," created by Lilly USA (NYSE: LLY ...om/value_of_medicine.jsp . The booklet supports Li..." and encourages an open dialogue with patients, p...al industry practices. ,, "Today, Lilly and ot...
(Date:12/1/2009)...re-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: D...ed to Chrono Nutraceuticals LLC exclusive rights i...ease dietary supplements using SCOLR,s proprietary...COLR granted Chrono rights to manufacture and sell...nexclusive basis. Chrono paid SCOLR $25,000 upon ...
Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Caliper Life Sciences to Webcast Investor Session of Open House 12528 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 2Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1..., Calif., June 10 /PRNewswire-FirstCall/ - Neuroge...pany focused on developing and,commercializing nov...publication of Phase 3 data of its lead product ca...aper, titled, "Controlled Trial in,High-Concentrat...europathy," will appear in the June 10, 2008 editi...
...rial Results Expected in Q3 2008, Conference Call...astern Time, MOU..., Inc. (Nasdaq: ALXA ) announced today that it ha...al trial with AZ-004 (Staccato(R),loxapine). AZ-00...ed for,the treatment of acute agitation in patient...
Other Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7...h specifically designed for laparoscopic hernia re... issues associated with laparoscopic procedures. M...enhanced maneuverability and retains a flat profil...h is the culmination of input and insight from lap...
...the treatment of all primary and recurrent indirec...t advantages over a conventional suture technique,... in a complete tension-free repair technique. The ...tation, and fewer recurrences.,The entire operati...
... wavelength with a unique flat beam profile to max... beam profile consistently delivers energy in the ...Lyra-I uniquely avoids high peak powers ensuring p...y patented continuous parallel contact cooling tha...
...orrhaphy. MERSILENE Polyester Fiber Mesh is a high...cellent strength, durability and surgical adaptabi...ssue ingrowth.,Mersilene Polyester Fiber Mesh is ...ame material used to make Mersilene Polyester Fibe...
Medicine Products: